Homogenous HIV-1 subtype B from the Brazilian Amazon with infrequent diverse BF1 recombinants, subtypes F1 and C among blood donors
Autoři:
Myuki Alfaia Esashika Crispim aff001; Mônica Nogueira da Guarda Reis aff002; Claudia Abrahim aff001; Dagmar Kiesslich aff001; Nelson Fraiji aff001; Gonzalo Bello aff003; Mariane Martins Araújo Stefani aff002
Působiště autorů:
Fundação de Hematologia e Hemoterapia do Amazonas/HEMOAM, Amazonas, Manaus, Brazil
aff001; Instituto de Patologia Tropical e Saúde Pública, Laboratório de Imunologia da AIDS e da Hanseniase, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
aff002; Instituto Oswaldo Cruz, FIOCRUZ, Laboratório de AIDS e Imunologia Molecular, Rio de Janeiro, Rio de Janeiro, Brazil
aff003
Vyšlo v časopise:
PLoS ONE 14(9)
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pone.0221151
Souhrn
In the last decade a growing HIV/AIDS epidemic with increased incidence and AIDS-related mortality has been reported in Northern Brazil from which molecular data are scarce. Also, apparently healthy, adult blood donors, recently diagnosed with HIV-1 represent important sentinel populations for molecular studies. This cross-sectional study describes HIV-1 subtypes in blood donors from three reference public blood centers located in three States in Northern Brazil. HIV-1 pol sequencing (protease/PR, reverse transcriptase/RT) was performed on plasma samples of HIV-1 positive donors from HEMOAM, Manaus, Amazonas (n = 198), HEMERON, Porto Velho, Rondônia (n = 20) and HEMORAIMA, Boa Vista, Roraima (n = 9) collected from 2011–2017. HIV-1 subtypes were identified by REGA, phylogenetic inference; recombinant viruses were characterized by SIMPLOT. Young, single, males predominated, around half was first-time donors. Syphilis co-infection was detected in 17% (39 out of 227), 8% (18 out of 227) was anti-HBc positive. Subtype B represented ≥ 90% in Amazonas, Rondônia and Roraima, subtype C (3.1%) was found in Amazonas and Rondônia; subtype F1 (0.9%) and BF1 recombinants (5.3%) were only detected in Amazonas. Subtype B sequences from Amazonas (n = 179), Rondônia (n = 18) and Roraima (n = 9) were combined with viral strains representative of the BPANDEMIC (n = 300) and BCARIBBEAN/BCAR (n = 200) lineages. The BPANDEMIC lineage predominated (78%) although BCAR lineages were frequent in Roraima (56%) and Amazonas (22%). Subtype C and subtype F1 sequences identified here clustered within Brazilian CBR and F1BR lineages, respectively. Twelve BF1 mosaics showed 11 different recombination profiles: six were singleton unique-recombinant-forms/URFs, one displays a CRF28/29_BF-like recombinant pattern and the remaining four BF1 isolates branched with other Brazilian BF1 viruses previously described and may represent putative new CRF_BF1 from Northern Brazil. Our study shows a highly homogeneous molecular pattern with prevalent subtype B, followed by BF1, and sporadic subtype C and F1 in blood donors from the Northern region. Surveillance studies are important to monitor HIV-1 diversity which can reveal patterns of viral dissemination, especially in a highly endemic, remote and geographically isolated region as Northern Brazil.
Klíčová slova:
People and places – Geographical locations – South America – Brazil – Biology and life sciences – Microbiology – Medical microbiology – Microbial pathogens – Viral pathogens – Immunodeficiency viruses – HIV – HIV-1 – Retroviruses – Lentivirus – Organisms – Viruses – RNA viruses – Evolutionary biology – Evolutionary systematics – Phylogenetics – Phylogenetic analysis – Taxonomy – Anatomy – Body fluids – Blood – Physiology – Medicine and health sciences – Pathology and laboratory medicine – Pathogens – Health care – Blood donors – Research and analysis methods – Database and informatics methods – Bioinformatics – Sequence analysis – Sequence alignment – Sequence databases – Biological databases – Computer and information sciences – Data management
Zdroje
1. Brazilian (2018) Ministry of Health. AIDS Epidemiological Bulletin [in Portuguese] July 2017-June 2018; volume 49 number 53. Available from http://www.aids.gov.br/pt-br/pub/2018/boletim-epidemiologico-hivaids-2018 (accessed august 5th 2019).
2. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically Infected individuals. Aids. 2003;17:1063–1069. doi: 10.1097/00002030-200305020-00016 12700457
3. Sprinz E, Netto EM, Patelli M, Lima JS, Furtado JJ, da Eira M, et al. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses. 2009;25:861–867. doi: 10.1089/aid.2009.0012 19689190.
4. Inocencio LA, Pereira AA, Sucupira MC, Fernandez JC, Jorge CP, Souza DF, et al. Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV. J Int AIDS Soc. 2017; 12: 20. doi: 10.1186/1758-2652-12-20 19765271.
5. Carvalho BC, Cardoso LP, Damasceno S, Stefani MM. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil. AIDS Res Hum Retroviruses. 2011; 27(10):1081–1087. doi: 10.1089/AID.2010.0334 21417758.
6. Ferreira AS, Cardoso LPV, and Stefani MMA. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. J Med Virol 2011; 83(8):1301–1307. doi: 10.1002/jmv.22128 21678433
7. Alencar CS, Sabino EC, Carvalho SM, Leao SC, Carneiro-Proietti AB, Capuani L, et al. HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV. J Acquir Immune Defic Syndr. 2013;63: 387–392. doi: 10.1097/QAI.0b013e31828ff979 23507660
8. Moura ME, da Guarda Reis MN, Lima YA, Eulálio KD, Cardoso LP, Stefani MM.HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil. J Med Virol. 2015;87(5):798–806. 2015 doi: 10.1002/jmv.24087 25649362.
9. Arruda MB, Boullosa LT, Cardoso CC, da Costa CM, Alves CR, de Lima S, et al Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals. J Int AIDS Soc. 2018; 21:33. doi: 10.1002/jia2.25032 29504269
10. Soares MA, De Oliveira T, Brindeiro RM, Diaz RS, Sabino EC, Brigido L, et al. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS. 2003;17(1):11–21. doi: 10.1097/00002030-200301030-00004 12478065
11. Soares EAJM, Martínez AMB, Souza TM, Santos AFA, Da Hora V, Silveira J,et al. HIV-1 subtype C dissemination in southern Brazil. AIDS. 2005;19 Suppl 4:S81–86. doi: 10.1097/00002030-200301030-00004 16249660
12. Stefani MM.; Pereira G.A.; Lins JA.; Alcantara KC.; Silveira AA. et al. Molecular screening shows extensive HIV-1 genetic diversity in Central West Brazil. J Clin Virol,. 2007; 39(3):205–209. doi: 10.1016/j.jcv.2007.04.012 17537671
13. Divino F. de Lima Guerra Corado A, Gomes Naveca F, Stefani MM, Bello G. High Prevalence and Onward Transmission of Non-Pandemic HIV-1 Subtype B Clades in Northern and Northeastern Brazilian Regions. PLoS One. 2016;11(9):e0162112. doi: 10.1371/journal.pone.0162112 27603317
14. Pessoa R, Loureiro P, Esther Lopes M, Carneiro-Proietti AB, Sabino EC, Busch MP, et al. UltraDeep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors. PLoS One. 2016;11: e0152499. doi: 10.1371/journal.pone.0152499 27031505
15. Lima K, Leal E, Cavalcanti AMS, Salustiano DM, de Medeiros LB, da Silva SP, et al. Increase in human immunodeficiency virus 1 diversity and detection of various subtypes and recombinants in north-eastern Brazil. J Med Microbiol. 2017;66(4):526–535. doi: 10.1099/jmm.0.000447 28425872
16. Reis MNG, Bello G, Guimarães ML, Stefani MMA. Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions. PLoS One. 2017;12(6):e0178578. eCollection 2017. doi: 10.1371/journal.pone.0178578 28628667.
17. da Costa CM, Costa de Oliveira CM, Chehuan de Melo YF, Delatorre E, Bello G, Couto-Fernandez JC. High HIV-1 Genetic Diversity in Patients from Northern Brazil. AIDS Res Hum Retroviruses. 2016;32(9):918–922. doi: 10.1089/AID.2016.0044 27091699
18. Reis MNG, Guimarães ML, Bello G, Stefani MMA. Identification of New HIV-1 Circulating Recombinant Forms CRF81_cpx and CRF99_BF1 in Central Western Brazil and of Unique BF1 Recombinant Forms. Front Microbiol. 2019.10:97. doi: 10.3389/fmicb.2019.00097 30804902
19. Vicente AC, Otsuki K, Silva NB, Castilho MC, Barros FS, Pieniazek D, Hu D, Rayfield MA, Bretas G, Tanuri A. The HIV epidemic in the Amazon Basin is driven by prototypic and recombinant HIV-1 subtypes B and F.J Acquir Immune Defic Syndr. 2000;23(4):327–331. 10836755
20. Machado LF, Ishak MO, Vallinoto AC, Lemos JA, Azevedo VN, Moreira MR, et al. Molecular epidemiology of HIV type 1 in northern Brazil: identification of subtypes C and D and the introduction of CRF02_AG in the Amazon region of Brazil. AIDS Res Hum Retroviruses. 2009;25(10):961–966. doi: 10.1089/aid.2009.0027 19795985
21. Cunha LK, Kashima S, Amarante MF, Haddad R, Rodrigues ES, Silva KL, et al. Distribution of human immunodeficiency vírus type1 subtype sin the State of Amazonas, Brazil, and subtypeC identification. Braz J Med Biol Res. 2012;45:104–112. doi: 10.1590/S0100-879X2012007500003 22249428
22. Macêdo O, Ferreira LM, Lopes CAF, Sousa RCM, Araújo JRM, Vasconcelos PFC. Distribution of HIV-1 subtypes in patients with HAART therapeutic failure in the States of Pará and Amazonas, Brazil: 2002 to 2006. Rev Pan-Amaz Saude. 2012;3(2):11–16.ISSN 2176-6215 On-line version ISSN 2176-6223. https://doi.org/10.5123/S2176-62232012000200002
23. Lopes CA, Soares MA, Falci DR, Sprinz E. The Evolving Genotypic Profile of HIV-1 Mutations Related to Antiretroviral Treatment in the North Region of Brazil. Biomed Res Int. 2015;2015:738528. doi: 10.1155/2015/738528 26543866.
24. Dos Anjos Silva L, Divino F, da Silva Rego MO, Lima Lopes IG, Nobrega Costa CM, da Silva Pereira FC, et al. HIV-1 Genetic Diversity and Transmitted Drug Resistance in Antiretroviral Treatment-Naive Individuals from Amapa State, Northern Brazil. AIDS Res Hum Retroviruses. 2016:32: 373–376. doi: 10.1089/AID.2015.0280 26529282.
25. Machado LF, Costa IB, Folha MN, da Luz AL, Vallinoto AC, Ishak R, et al. Lower genetic variability of HIV-1 and antiretroviral drug resistance in pregnant women from the state of Pará, Brazil. BMC Infect Dis. 2017;17(1):270. doi: 10.1186/s12879-017-2392-y 28403828
26. Corado A L, Bello G, Leão R A, Granja F, Naveca F G. HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil. PLoS One. 2017;12(3) e0173894. doi: 10.1371/journal.pone.0173894 28301548
27. Andrade S D, Sabidó M, Monteiro W M, Benzaken A ST, Tanuri A. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas. J Antimicrob Chemother. 2017;72(6):1774–1783. doi: 10.1093/jac/dkx025 28333295
28. Viga-Yurtsever S, Fraiji N, Lira E, Stefani M, Kiesslich D. High rate of HIV infection in voluntary, first time, young male donos at HEMOAM, a reference blood bank in the Brazilian Amazon: 1992–2012 historical series. ISBT Science Series. 2015;10:18–26. https://doi.org/10.1111/voxs.12170
29. BRASIL. Ministério do Planejamento, Orçamento e Gestão. Instituto Brasileiro de Geografia e Estatística. Contagem Populacional. Available from http:// https://www.ibge.gov.br/estatisticas-novoportal/por-cidade-estado-estatisticas.html>.
30. Frenkel LM, Wagner LE, Atwood SM, Cummins TJ, Dewhurst S. Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine. J Clin Microbiol. 1995; 33:342–347. 7714190
31. Kozal MJ, Shah N, Shen N, Yang R, Fucini R, Merigan T, et al. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med 1996;2:753–759. 8673920
32. Lehvaslaiho H, Hide W, and Oliveira T: South African National Bioinformatics Institute, University of Western Cape, South Africa. Available from http://www.sanbi.ac.za. Accessed January, 2018.
33. Hall TA: BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95 = 98 = MT. Nucleic Acids Symp Ser 1999;41:95–98.
34. Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005;21:3797–3800. doi: 10.1093/bioinformatics/bti607 16076886
35. Zhang M, Schultz AK, Calef C, Kuiken C, Leitner T, Korber B, et al. jpHMM at GOBICS: a web server to detect genomic recombinations in HIV-1. Nucleic Acids Res. 2006;34:463–465. doi: 10.1093/nar/gkl255 16845050
36. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876–4882. doi: 10.1093/nar/25.24.4876 9396791
37. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111–120. 7463489
38. Tamura K, Stecher G, Peterson D, Filipski A and Kumar S. MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30(12:2725–2729. doi: 10.1093/molbev/mst197 24132122
39. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152–160. 9847317
40. Mendoza Y, Martinez AA, Castillo Mewa J, Gonzalez C, Garcia-Morales C, Avila-Rios S, et al. Human Immunodeficiency Virus Type 1 (HIV-1) Subtype B Epidemic in Panama Is Mainly Driven byDissemination of Country-Specific Clades. PLoS ONE. 2014; 9(4):e95360. doi: 10.1371/journal.pone.0095360 24748274.
41. Cabello M, Mendoza Y, Bello G. Spatiotemporal dynamics of dissemination of non-pandemic HIV-1 subtype B clades in the Caribbean region. PLoS One. 2014;9: e106045. doi: 10.1371/journal.pone.0106045 25148215
42. Cabello M, Junqueira DM, Bello G. Dissemination of nonpandemic Caribbean HIV-1 subtype B clades in Latin America. AIDS. 2015;29:483–492. doi: 10.1097/QAD.0000000000000552 25630042
43. Bello G, Afonso JM, Morgado MG. Phylodynamics of HIV-1 subtype F1 in Angola, Brazil and Romania. Infect Genet Evol. 2012;12(5):1079–1086. doi: 10.1016/j.meegid.2012.03.014 22484759
44. Delatorre E, Bello G. Phylodynamics of HIV-1 Subtype C Epidemic in East Africa. PLoS ONE. 2012;7(7):e41904. doi: 10.1371/journal.pone.0041904 22848653
45. Delatorre E, Couto-Fernandez JC, Guimaraes ML, Vaz Cardoso LP, de Alcantara KC, Stefani MM, et al. Tracing the origin and northward dissemination dynamics of HIV-1 subtype C in Brazil. PLoS ONE. 2013;8(9):e74072. doi: 10.1371/journal.pone.0074072 24069269
46. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59: 307–321. doi: 10.1093/sysbio/syq010 20525638.
47. Lefort V, Longueville JE, Gascuel O. SMS. Smart Model Selection in PhyML.Mol Bio Evol.2017;34(9):2422–2424. doi: 10.1093/molbev/msx149 28472384
48. Anisimova M, Gascuel O. Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst Biol. 2006;55(4):539–52. doi: 10.1080/10635150600755453 16785212
49. Castro E, Echeverría G, Deibis L, González de Salmen B, Dos Santos Moreira A, Guimarães ML, Bastos FI, Morgado MG. Molecular epidemiology of HIV-1 in Venezuela: high prevalence of HIV-1 subtype B and identification of a B/F recombinant infection.J Acquir Immune Defic Syndr. 2003;32(3):338–344. 12626896
50. Villalba JA1, Bello G, Maes M, Sulbaran YF, Garzaro D, Loureiro CL, Rangel HR, de Waard JH, Pujol FH. HIV-1 epidemic in Warao Amerindians from Venezuela: spatial phylodynamics and epidemiological patterns. AIDS. 2013;27(11):1783–1791. doi: 10.1097/QAD.0b013e3283601bdb 23435304
51. Bello G, Nacher M, Divino F, Darcissac E, Mir D, Lacoste. The HIV-1 Subtype B Epidemic in French Guiana and Suriname Is Driven by Ongoing Transmissions of Pandemic and Non-pandemic Lineages. Front Microbiol. 2018;9:1738. eCollection 2018. doi: 10.3389/fmicb.2018.01738 30108576.
52. Esashika Crispim MA, da Guarda Reis MN, Fraiji N, Bello G, Stefani MMA. Detection of human immunodeficiency virus Type 1 phylogenetic clusters with multidrug resistance mutations among 2011 to 2017 blood donors from the highly endemic Northern Brazilian Amazon. Transfusion. 2019. [Epub ahead of print] doi: 10.1111/trf.15347 31119759.
53. Thomaz D. Post disaster Haitian migration. Forced Migration Rev. 2013;43:35–36.
54. Pessôa R, Watanabe JT, Calabria P, Felix AC, Loureiro P, Sabino EC, et al. Deep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, Brazil. PLoS One. 2014;9(11):e112674. doi: 10.1371/journal.pone.0112674 25401747
55. Pessôa R, Carneiro Proietti AB, Busch MP, Sanabani SS. Identification of a Novel HIV-1 Circulating Recombinant Form (CRF72_BF1) in Deep Sequencing Data from Blood Donors in Southeastern Brazil. Genome Announc. 2014;2(3). doi: 10.1128/genomeA.00386-14 24926043
56. Sanabani S, Kleine Neto W, Kalmar EM, Diaz RS, Janini LM, Sabino EC. Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in São Paulo, Brazil. Infect Genet Evol. 2006;6(5):368–377. doi: 10.1016/j.meegid.2006.01.003 16522378
57. Gray RR, Tatem AJ, Lamers S, Hou W, Laeyendecker O, Serwadda D, et al. Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. AIDS. 2009;23(14):F9–F17. doi: 10.1097/QAD.0b013e32832faf61 19644346.
Článek vyšel v časopise
PLOS One
2019 Číslo 9
- Tisícileté topoly, mokří psi, stárnoucí kočky a ospalé octomilky – „jednohubky“ z výzkumu 2024/41
- Jaké jsou aktuální trendy v léčbě karcinomu slinivky?
- Může hubnutí souviset s vyšším rizikem nádorových onemocnění?
- Menstruační krev má značný diagnostický potenciál, mimo jiné u diabetu
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
Nejčtenější v tomto čísle
- Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
- Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
- Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
Zvyšte si kvalifikaci online z pohodlí domova
Všechny kurzy